Amiodarone-induced skin pigmentation and pulmonary fibrosis

Hospital Pharmacy

Volumn 37, Issue 6, 2002, Pages 615-618

  González, Pilar ^a   Otero, María José ^a   Barrueco, Miguel ^a   Domínguez Gil, Alfonso ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Amiodarone; Follow up; Pulmonary toxicity; Skin toxicity

Indexed keywords

AMIODARONE; DIGOXIN; PREDNISONE;

AGED; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DRUG SAFETY; DRUG WITHDRAWAL; HEART SUPRAVENTRICULAR ARRHYTHMIA; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FIBROSIS; MALE; PIGMENT DISORDER; SKIN TOXICITY; THORAX RADIOGRAPHY;

EID: 0036278767     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857870203700616     Document Type: Article

References (21)

1. Clinical efficacy of amiodarone
2. Oral amiodarone: Historical overview and development
3. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiac care
4. Amiodarone: Reevaluation of an old drug
5. Classification and pharmacology of antiarrhythmic drugs
6. Pharmacokinetics of amiodarone: Implications for drug therapy
7. Optimal management of amiodarone therapy: Efficacy and side effects
8. Rationale, development, and clinical outcomes of a multidisciplinary amiodarone clinic
9. Adverse effects of low dose amiodarone: A meta-analysis
10. Practical guidelines for clinicians who treat patients with amiodarone
11. Amiodarone pulmonary toxicity. Recognition and pathogenesis (part 1)
12. Clinical features of amiodarone-induced pulmonary toxicity
13. Amiodarone pulmonary toxicity: A multidisciplinary review of current status
14. Amiodarone pulmonary toxicity: Dose and duration of treatment are not the only determinants of toxicity
15. Amiodarone-induced pulmonary toxicity
16. Photosensitivity and hyperpigmentation in amiodarone-treated patients: Incidence, time course and recovery
17. Dose-dependent appearance and disappearance of amiodarone-induced skin pigmentation
18. Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser
19. Amiodarone: A postmarketing evaluation of monitoring for drug-induced toxicity
20. Seguimiento de la función tiroidea en pacientes tratados con amiodarona